Health Condition 1: null- Healthy ASA 1 and ASA 2 patients coming for breast cancer surgery
Conditions
Interventions
Intervention1: Levo Bupivicaine 0.25%: Local aanesthetic agent
Intervention2: Levo Bupivicaine 0.25%: Local anaesthetic agent
Control Intervention1: No drug given: Control group with no local anaesth
Sponsors
Fluid research grant
Eligibility
Inclusion criteria
Inclusion criteria: 1.All ASA 1 and 2 consenting patients for breast cancer surgery with axillary clearance
Exclusion criteria
Exclusion criteria: 1.ASA 3 and 4 patients 2.Non consenting patients 3.Allergy to anesthetic drugs 4.chest wall abnormalities 5.Patients on anti-coagulants and anti platelets
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decreased postoperative pain and decreased use of intra-op opioidsTimepoint: Post op day 1 2 and 3 | — |
Secondary
| Measure | Time frame |
|---|---|
| decreased chronic painTimepoint: 6 months | — |
Countries
India
Contacts
Public ContactAnna Benjamin pullimood
Christian Medical College
Outcome results
None listed